CAS: 3615-24-5; Ramifenazone

该化合物是一种非类固醇抗炎药物,属于丙酮类,以其止痛,抗热和抗炎特性著称,其功能是抑制环氧酶(COX),从而减少丙烯酸酯合成. Ramifenazone因其在调控轻度至中度疼痛和炎症方面的功效而特别受重视,与一些传统的非氨基甲酸酯相比,其可耐性状况更有利. 它的代谢途径和药用植物对降低胃肠刺激的风险,使其成为短期治疗的合适选择. 该化合物通常在临床环境中用于治疗肌肉骨骼紊乱和后期疼痛等情况. 进一步研究继续探索其全部治疗潜力.

结构式图片

上下游产品

CAS号885-11-0 亚硝基安替比林 | CAS号67-64-1 丙酮 | CAS号83-07-8 4-氨基安替比林 | CAS号75-26-3 2-溴丙烷 | CAS号15572-56-2 异丙胺盐酸盐 | CAS号81217-09-6 N-(1,5-dimethyl... | CAS号81217-10-9 N-(1,5-dimethyl... | CAS号81217-11-0 N-(1,5-dimethyl...

合成工艺路线路线简述

  • 合成目标产物 Ramifenazone 主要起始原料 4-Aminoantipyrine And 2-Bromopropane
  • (文献来源)合成步骤主要原料 4-Aminoantipyrine 和 2-Bromopropane
📜2,3-二甲基-4-亚硝基-1-苯基-3-吡唑啉-5-酮,丙酮置于镍体系中,化学反应生成异丙氨基比林
参考文献:De742438
标题:De742438

海关参考信息

专利信息


专利号:US-8546532-B2
优先权日:2008-04-17
标题:Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
发明人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS
权利人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS; DECLION PHARMACEUTICALS INC
摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. The invention also pertains to the process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.

专利号:US-9051302-B2
优先权日:2008-01-15
标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

专利号:US-2024287041-A1
优先权日:2021-05-20
标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

专利号:AU-2022276509-A1
优先权日:2021-05-20
标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

专利号:US-9994558-B2
优先权日:2013-09-20
标题 :Multicyclic compounds and methods of using same
发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

专利号:WO-2022246227-A1
优先权日:2021-05-20
标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Dowling G, Malone E. Analytical strategy for the confirmatory analysis of the non-steroidal anti-inflammatory drugs firocoxib, propyphenazone, ramifenazone and piroxicam in bovine plasma by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2011 Sep 10;56(2):359-65. doi: 10.1016/j.jpba.2011.05.029. Epub 2011 May 23. doi: 10.1007/s00216-015-8634-1. Epub 2015 Mar 27.

合成参考文献


摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知